Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model
ContextA predictive model of mortality in heart failure may be useful for clinicians to improve
communication with and care of hospitalized patients.ObjectivesTo identify predictors of …
communication with and care of hospitalized patients.ObjectivesTo identify predictors of …
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national …
Background— The contributions of risk factors and disease pathogenesis to heart failure
with preserved ejection fraction (HFPEF) versus heart failure with reduced ejection fraction (…
with preserved ejection fraction (HFPEF) versus heart failure with reduced ejection fraction (…
[HTML][HTML] Outcome of heart failure with preserved ejection fraction in a population-based study
Background The importance of heart failure with preserved ejection fraction is increasingly
recognized. We conducted a study to evaluate the epidemiologic features and outcomes of …
recognized. We conducted a study to evaluate the epidemiologic features and outcomes of …
[HTML][HTML] Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
DN Juurlink, MM Mamdani, DS Lee… - … England Journal of …, 2004 - Mass Medical Soc
Background The Randomized Aldactone Evaluation Study (RALES) demonstrated that
spironolactone significantly improves outcomes in patients with severe heart failure. Use of …
spironolactone significantly improves outcomes in patients with severe heart failure. Use of …
Introduction to the analysis of survival data in the presence of competing risks
Competing risks occur frequently in the analysis of survival data. A competing risk is an
event whose occurrence precludes the occurrence of the primary event of interest. In a study …
event whose occurrence precludes the occurrence of the primary event of interest. In a study …
Risk-treatment mismatch in the pharmacotherapy of heart failure
ContextPatients with heart failure have a wide spectrum of mortality risks. To maximize the
benefit of available pharmacotherapies, patients with high mortality risk should receive high …
benefit of available pharmacotherapies, patients with high mortality risk should receive high …
Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study
Objective— To determine whether serum γ-glutamyl transferase (GGT) predicts cardiovascular
disease (CVD) morbidity and mortality, accounting for temporal changes in known CVD …
disease (CVD) morbidity and mortality, accounting for temporal changes in known CVD …
[HTML][HTML] Association of parental heart failure with risk of heart failure in offspring
Background The association between heart failure in parents and the prevalence of left
ventricular systolic dysfunction and the risk of heart failure in their offspring has not been …
ventricular systolic dysfunction and the risk of heart failure in their offspring has not been …
Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis
Objectives : The aim of this study was to compare the effectiveness of the implantable cardioverter
defibrillator (ICD) and medical strategies for prevention of arrhythmic events and death…
defibrillator (ICD) and medical strategies for prevention of arrhythmic events and death…
Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction
Background— Atrial fibrillation (AF) and heart failure (HF) frequently coexist and together
confer an adverse prognosis. The association of AF with HF subtypes has not been well …
confer an adverse prognosis. The association of AF with HF subtypes has not been well …